Position in TWST
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$545,264
+$210,248 QoQ
Shares Held
5,300
-24.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
10 quarters on record
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $3,299,056 across 37 Biotechnology names. TWST ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GALT |
Galectin Therapeutics Inc
|
240,427 | $1,115,581 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
12,199 | $954,815 | |
| 3 | TWST |
Twist Bioscience Corp
This page
|
5,300 | $545,264 | |
| 4 | AVXL |
Anavex Life Sciences Corp.
|
48,100 | $124,579 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $85,424 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
1,269 | $69,718 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
5,754 | $50,376 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $50,169 |
All Filings in TWST
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $545,264 | 5,300 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $335,016 | 7,050 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $283,894 | 8,950 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $153,363 | 5,450 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $97,493 | 2,650 | Shares | Sole | 2025-08-18 | |
| 2021-12-31 | $218,626 | 2,825 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $355,675 | 3,325 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $323,131 | 2,425 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $77,412 | 625 | Shares | Sole | 2021-06-17 | |
| 2020-12-31 | $194,273 | 1,375 | Shares | Sole | 2021-05-19 | |
| No filing history on record for this holder in this stock. | ||||||